Boston Scientific (NYSE:BSX) announced its fourth-quarter results, which were better than expected, leading to a 4% increase in its shares intra-day today.
The medical device company reported adjusted earnings per share (EPS) of 55 cents for the fourth quarter, up from 45 cents in the same period the previous year and surpassing the consensus estimate of 51 cents. Boston Scientific’s net sales also saw a notable year-over-year increase of 15% to $3.73 billion, outperforming the projected $3.6 billion.
Looking to the upcoming first quarter, Boston Scientific expects an adjusted EPS of between 50 and 52 cents, compared to the consensus estimate of 52 cents.
For the entire year, the company is projecting an adjusted EPS to range from $2.23 to $2.27, compared to the analysts’ estimate of $2.24.